Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS PROVIDES OPERATIONAL UPDATE – Continues to supply essential cardiovascular solutions to patients around the world

24 March 2020

OPSENS PROVIDES OPERATIONAL UPDATE Continues to supply essential cardiovascular solutions to patients around the world Quebec City, Quebec, March 24, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today provided a business update in light of recent action taken…

Read more

OPSENS RECEIVES dPR CLEARANCE FROM FDA

19 December 2019

Opsens Receives dPR Clearance from the FDA Product approval will bolster U.S. commercial efforts Quebec City, Quebec, December 19, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announces 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its diastolic pressure algorithm (“dPR”). Coronary physiology has been in constant evolution with…

Read more

VISIT OPSENS AT SCAI FALL FELLOWS 2019

2 December 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the SCAI Fall Fellows 2019 Annual Meeting by attending Opsens’ complimentary educational symposium. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second…

Read more

OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41%

14 November 2019

OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41% Quebec City, Quebec, November 14, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for 2019. Highlights FOR THE QUARTER AND FOR THE YEAR Record consolidated revenues at $32.8 M for…

Read more

OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET

5 November 2019

OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET Expands core technology into fastest growing segment of cardiology devices Quebec City, Quebec, November 5, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announces today it is expanding its medical device business into the structural cardiology space and will accelerate development activities of products that reach…

Read more

Visit Opsens at TCT 2019

4 September 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at TCT 2019 (Transcatheter Cardiovascular Therapeutics 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%

11 July 2019

Quebec City, Quebec, July 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2019. Highlights Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%; Fractional…

Read more

Visit Opsens at CVI 2019

2 July 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at CVI 2019 (Cardiovascular Innovations 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

Learn from coronary physiology KOLs after EuroPCR 2019

30 June 2019
EuroPCR 2019 - Emanuele Barbota EuroPCR 2019 - Morton J Kern

OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER

17 June 2019

Paris – Le Bourget, France, June 17, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. (“Opsens Solutions”), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L.  (“Temai”) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a…

Read more